Lipopolysaccharide-induced leukocyte lipid body formation in vivo: Innate immunity elicited intracellular loci involved in eicosanoid metabolism

Journal of Immunology

Volumn 169, Issue 11, 2002, Pages 6498-6506

  Pacheco, Patrícia ^a   Bozza, Fernando A ^a,b   Gomes, Rachel N ^a   Bozza, Marcelo ^b   Weller, Peter F ^c   Castro Faria Neto, Hugo C ^a   Bozza, Patrícia T ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; CYCLOOXYGENASE 2; CYTOKINE; ICOSANOID; LEUKOTRIENE B4; LIPID; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAZIL; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; IMMUNITY; IMMUNOLOCALIZATION; INFECTION RESISTANCE; INFLAMMATION; LEUKOCYTE; LIPID BODY; MALE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; SEPSIS; TIME; ANIMAL; C3H MOUSE; CASE CONTROL STUDY; CBA MOUSE; DRUG EFFECT; IMMUNOLOGY; LIPID METABOLISM; METABOLISM; MIDDLE AGED; MOUSE; PATHOLOGY; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; ANTIGENS, CD14; ARACHIDONATE 5-LIPOXYGENASE; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; EICOSANOIDS; FEMALE; HUMANS; INCLUSION BODIES; INFLAMMATION MEDIATORS; ISOENZYMES; LEUKOCYTES; LIPID METABOLISM; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED CBA; MIDDLE AGED; PLATELET ACTIVATING FACTOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SEPSIS; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036884466     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.11.6498     Document Type: Article

References (67)

1. Medzhitov, R., and C. J. Janeway. 2000. Innate immunity. N. Engl. J. Med. 343:338.
2. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457.
3. Alexander, C., and E. T. Rietschel. 2001. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7:167.
4. Bulger, E. M., and R. V. Maier. 2000. Lipid mediators in the pathophysiology of critical illness. Crit. Care Med. 28:N27.
5. Mathiak, G., D. Szewczyk, F. Abdullah, P. Ovadia, and R. Rabinovici. 1997. Platelet-activating factor (PAF) in experimental and clinical sepsis. Shock 7:391.
6. Funk, C. D. 2002. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871.
7. 2 in eicosanoid generation. Am. J. Respir. Crit. Care Med. 161:S32.
8. Morita, I., M. Schindler, M. K. Regier, J. C. Otto, T. Hori, D. L. DeWitt, and W. L. Smith. 1995. Different intracellular locations for prostaglandin endoperoxide synthases-1 and -2. J. Biol. Chem. 270:10902.
9. Smith, W. L., R. M. Gravito, and D. L. DeWitt. 1996. Prostaglandin endoper-oxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271:33157.
10. Rouzer, C. A., and S. Kargman. 1988. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J. Biol. Chem. 263:10980.
11. Woods, J. W., M. J. Coffey, T. G. Brock, I. I. Singer, and M. Peters-Golden. 1995. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95:2035.
12. Woods, J. W., J. F. Evans, D. Ethier, S. Scott, P. J. Vickers, L. Hearn, J. A. Heibein, S. Charleson, and I. I. Singer. 1993. 5-Lipoxygenase and 5-lipoxygenase-activing protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935.
13. Gilmour, R. S., and M. D. Mitchell. 2001. Nuclear lipid signaling: novel role of eicosanoids. Exp. Biol. Med. 226:1.
14. Weller, P. F., P. T. Bozza, W. Yu, and A. M. Dvorak. 1999. Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. Int. Arch. Allergy Immunol. 118:450.
15. Murphy, D. J. 2001. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 40:325.
16. Weller, P. F., R. A. Monahan-Earley, H. F. Dvorak, and A. M. Dvorak. 1991. Cytoplasmic lipid bodies of human eosinophils: subcellular isolation and analysis of arachidonic incorporation. Am. J. Pathol. 138:141.
17. Bozza, P. T., W. Yu, J. Cassara, and P. F. Weller. 1998. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J. Leukocyte Biol. 64:563.
18. Coimbra, A., and A. Lopes-Vaz. 1971. The presence of lipid droplets and the absence of stable sudanophilia in osmium-fixed human leukocytes. J. Histochem. Cytochem. 19:551.
19. Bozza, P. T., J. L. Payne, S. G. Morham, R. Langenbach, O. Smithies, and P. F. Weller. 1996. Leukocytes lipid body formation and eicosanoids generation: cyclooxygenase-independent inhibition by aspirin. Proc. Natl. Acad. Sci. USA 92:11091.
20. Triggiani, M., A. Oriente, M. C. Seeds, D. A. Bass, G. Marone, and F. H. Chilton. 1995. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J. Exp. Med. 182:1181.
21. Bozza, P. T., W. Yu, J. F. Penrose, E. S. Morgan, A. M. Dvorak, and P. F. Weller. 1997. Eosinophils lipid bodies: specific, inducible intracellular sites for enhanced eicosanoids formation. J. Exp. Med. 186:909.
22. 2 at cytoplasmic lipid bodies of U937 cells. Am. J. Pathol. 152:759.
23. Yu, W., J. Cassara, and P. F. Weller. 2000. Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood 95:1078.
24. Dvorak, A. M., E. Morgan, D. M. Tzizik, and P. F. Weller. 1994. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to non-membrane-bound cytoplasmic lipid bodies in human eosinophils and murine 3T3 fibroblasts. Int. Arch. Allergy Immunol. 105:245.
25. Bozza, P. T., J. L. Payne, J. L. Goulet, and P. F. Weller. 1996. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J. Exp. Med. 783:1515.
26. 4 production in eosinophils and basophils. J. Biol. Chem. 276:22779.
27. Bartemes, K. R., S. McKinney, G. J. Gleich, and H. Kita. 1999. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J. Immunol. 162:2982.
28. Bozza, P. T., P. Pacheco, W. Yu, and P. F. Weller. 2002. NS-398: cyclooxygenase-2 independent inhibition of leukocyte priming for lipid body formation and enhanced leukotriene generation. Prostaglandins Leukot. Essent. Fatty Acids. In press.
29. Bandeira-Melo, C., P. T. Bozza, and P. F. Weller. 2002. The cellular biology of eosinophil eicosanoid formation and function. J. Allergy Clin. Immunol. 109:393.
30. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644.
31. Penido, C., H. C. Castro-Faria-Neto, A. P. Larangeira, E. C. Rosas, R. Ribeiro-dos-Santos, P. T. Bozza, and M. G. Henriques. 1997. The role of γδ T lymphocytes in lipopolysaccharide-induced eosinophil accumulation into the mouse pleural cavity. J. Immunol. 159:853.
32. Silva, A. R., E. F. de Assis, L. F. C. Caiado, G. K. Marathe, M. T. Bozza, T. M. McIntyre, G. A. Zimmerman, S. M. Prescott, P. T. Bozza, and H. C. Castro-Faria-Neto. 2002. MCP-1 and 5-lipoxygenase products recruit leukocytes in response to PAF-like lipids in oxidized LDL. J. Immunol. 168:4112.
33. Bozza, P. T., H. C. Castro-Faria-Neto, A. R. Silva, A. P. Larangeira, P. M. R. Silva, M. A. Martins, and R. S. B. Cordeiro. 1994. Lipopolysaccharide-induced pleural neutrophil accumulation depends on marrow neutrophils and platelet-activating factor. Eur. J. Pharmacol. 270:143.
34. Kopaniak, M. M., A. C. Issekutz, and H. Z. Movat. 1980. Kinetics of acute inflammation induced by E. coli in rabbits: quantitation of blood flow, enhanced vascular permeability, hemorrhage, and leukocyte accumulation. Am. J. Pathol. 98:485.
35. Colditz, I. G., and H. Z. Movat. 1984. Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. J. Immunol. 133:2169.
36. Bozza, P. T., H. C. Castro-Faria-Neto, M. A. Martins, A. P. Larangeira, J. E. Perales, P. M. Silva, and R. S. Cordeiro. 1993. Pharmacological modulation of lipopolysaccharide-induced pleural eosinophilia in the rat: a role for a newly generated protein. Eur. J. Pharmacol. 248:41.
37. Ulevitch, R. J., and P. S. Tobias. 1999. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11:19.
38. Surette, M. E., R. Palmantier, J. Gosselin, and P. Borgeat. 1993. Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen. J. Exp. Med. 178:1347.
39. O'Sullivan, M. G., F. H. Chilton, E. M. J. Huggins, and C. E. McCall. 1992. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J. Biol. Chem. 267:14547.
40. Lin, W. W. 1997. Priming effects of lipopolysaccharide on UTP-induced arachidonic acid release in RAW 264.7 macrophages. Eur. J. Pharmacol. 321:121.
41. 4 in chemotactic peptide-stimulated human neutrophils. FASEB J. 12:1521.
42. Schimke, J., J. Mathison, J. Morgiewicz, and R. J. Ulevitch. 1998. Anti-CD14 mAb treatment provides therapeutic benefit after exposure to endotoxin. Proc. Natl. Acad. Sci. USA 95:13875.
43. Leturcq, D., A. M. Moriarty, G. Talbott, R. K. Winn, T. R. Martin, and R. J. Ulevitch. 1996. Antibodies against CD14 protect primates from endotoxin-induced shock. J. Clin. Invest. 98:1533.
44. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4:407.
45. Wright, S. D., and M. T. Jong. 1986. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164:1876.
46. Ingalls, R. R., and D. T. Golenbock. 1995. CD11c/CD18, a transmembrane signalling receptor for lipopolysaccharide. J. Exp. Med. 181:1473.
47. 2 integrin in vivo. J. Leukocyte Biol. 59:145.
48. Perera, P. Y., T. N. Mayadas, O. Takeuchi, S. Akira, M. Zaks-Zilberman, S. M. Goyert, and S. N. Vogel. 2001. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and Taxol-inducible gene expression. J. Immunol. 166:574.
49. n gene: in vivo evidence for a dominant negative mutation. J. Immunol. 162:5666.
50. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.
51. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 184:615.
52. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 284:2085.
53. Apte, R. N., O. Ascher, and D. H. Pluznik. 1977. Genetic analysis of generation of serum interferon by bacterial lipopolysaccharide. J. Immunol. 119:1898.
54. Rosenstreich, D. L., S. N. Vogel, A. R. Jacques, L. M. Wahl, and J. J. Oppenheim. 1978. Macrophage sensitivity to endotoxin: genetic control by a single codominant gene. J. Immunol. 121:1664.
55. Rylander, R., and L. Beijer. 1987. Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. Am. Rev. Respir. Dis. 135:83.
56. Chang, S. W., C. O. Feddersen, P. M. Henson, and N. F. Voelkel. 1987. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J. Clin. Invest. 79:1498.
57. Imaizumi, T. A., D. M. Stafforini, Y. Yamada, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1995. Platelet-activating factor: a mediator for clinicians. J. Intern. Med. 238:5.
58. Bazan, N. G., B. S, Fletcher, H. R. Herschman, and P. K. Mukherjee. 1994. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc. Natl. Acad. Sci. USA 91:5252.
59. Calabrese, C., M. Triggiani, G. Marone, and G. Mazzarella. 2000. Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma. Allergy 55:27.
60. Johnson, M. M., B. Vaughn, M. Triggiani, D. D. Swan, A. N. Fonteh, and F. H. Chilton. 1999. Role of arachidonyl triglycerides within lipid bodies in eicosanoid formation by human polymorphonuclear cells. Am. J. Respir. Cell Mol. Biol. 21:253.
61. Beil, W. J., P. F. Weller, M. A. Peppercorn, S. J. Galli, and A. M. Dvorak. 1995. Ultrastructural immunogold localization of subcellular sites of TNF-α in colonic Crohn's disease. J. Leukocyte Biol. 58:284.
62. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263:5380.
63. Hubbard, N. E., D. Lim, S. D. Somers, and K. L. Erickson. 1993. Effects of in vitro exposure to arachidonic acid on TNF-α production by murine peritoneal macrophages. J. Leukocyte Biol. 54:105.
64. 2-stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407). Scand. J. Gastroenterol. 28:323.
65. 2 production in resting macrophages. Biochem. Biophys. Res. Commun. 136:94.
66. 2 and cyclic nucleotides. J. Immunol. 141:2388.
67. Jayadev, S., C. M. Linardic, and Y. A. Hannun. 1994. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J. Biol. Chem. 269:5757.